Archives
-
nPEC for Dual-Loaded Liposome Encapsulation
2026-09-02
The reference study systematically compares separation strategies for measuring encapsulation efficiency when liposomes contain both hydrophilic and lipophilic drugs. Its validated nanoparticle exclusion chromatography method enables simultaneous online analysis and offers a practical alternative to more restricted or labor-intensive workflows.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-09-02
Lambda Protein Phosphatase, also called λ-PPase, provides Mn²⁺-dependent removal of phosphate groups from pSer, pThr, pTyr, and pHis residues. Its defined activity conditions support phosphorylation site validation, phospho-specific antibody testing, and controlled BMAL1 experiments, while the enzyme cannot by itself identify a phosphorylation site or prove causality.
-
Puromycin dihydrochloride: Selection & Translation
2026-09-01
Puromycin dihydrochloride combines fast, stringent selection of pac-expressing cell lines with a reversible way to interrogate protein synthesis. This guide translates its chemistry into reproducible workflows for stable NSCLC models, translation assays, and ribosome-focused experiments, with practical controls for stress-related confounding.
-
CD59–JAK2–STAT3 Signaling in Pancreatic Cancer
2026-09-01
The reference study identifies CD59 as a tumor cell-intrinsic driver of pancreatic cancer growth and connects it mechanistically to a JAK2–STAT3–CACNA1D signaling axis. Its combination experiments further show that CD59 or STAT3 blockade can improve the response to KRAS inhibition, providing a framework for studying adaptive resistance in pancreatic ductal adenocarcinoma.
-
B. fragilis Gut-Brain Cholinergic Seizure Control
2026-08-31
Jia et al. identify a gut–vagus–brain cholinergic circuit through which Bacteroides fragilis suppresses seizures in experimental models and improves outcomes in pediatric refractory epilepsy. The study combines microbiome analysis, neural recordings, pharmacological and chemogenetic tests, and a randomized clinical trial to connect microbial composition with a defined host neural pathway.
-
Human PSCs to Right Ventricular Cardiomyocytes
2026-08-31
Saito and colleagues developed a modified cardiac differentiation strategy that enriches right ventricular-like cardiomyocytes from human pluripotent stem cells by altering BMP-related signaling during mesoderm formation. The resulting cells showed chamber-associated molecular and functional differences, providing a useful framework for modeling diseases that preferentially affect the right ventricle.
-
iPSC Prescreening for Ultrarare Disease Trials
2026-08-30
Sequiera and colleagues developed a patient-specific iPSC platform to estimate drug safety and efficacy before clinical-trial enrollment in an ultrarare Leigh-like mitochondrial disorder. The study links disease modeling with longitudinal clinical decision-making and shows how personalized prescreening may reduce trial-and-error treatment for patients whose pathogenic variants lack established therapeutic evidence.
-
Protease and Phosphatase Inhibitor Cocktail Workflow
2026-08-29
Protect total protein and phosphorylation-dependent signals from the moment a sample is disrupted. This practical workflow shows how an EDTA-free, 100X formulation can support organoid, mammalian-cell, tissue, and multi-omics studies without introducing unwanted metal chelation.
-
LLY-507 SMYD2 Inhibitor: Assay Workflows
2026-08-28
LLY-507 combines nanomolar biochemical potency with strong SMYD2 selectivity for mechanism-led cancer and fibrosis research. This guide translates its substrate-pocket mechanism into dose-response, methylation, proliferation, apoptosis, and cisplatin-injury workflows, with practical controls for reproducible results.
-
Cefotaxime: From Resistance Genes to Assays
2026-08-28
Cefotaxime can connect beta-lactam antibiotic mechanism studies with genotype-aware antimicrobial resistance research. This guide explains how to use its phenotype as one layer in bacterial infection models without mistaking cephalosporin susceptibility for a direct readout of carbapenemase transmission.
-
Uridine, Trisodium Salt in Cell Assays
2026-08-27
This scenario-based guide explains how Uridine, Trisodium Salt (SKU B1473) can be incorporated into cell viability, proliferation, cytotoxicity, RNA metabolism, and vascular research workflows without confusing metabolic effects with assay readouts. It covers experimental controls, stock preparation, interpretation, and evidence-based product selection.
-
GANT61 and GLI2-Driven Ferroptosis Research
2026-08-27
GANT61 is a GLI inhibitor that enables precise investigation of Hedgehog transcriptional output, ferroptosis, and cisplatin response. This article translates recent GLI2–PRDX1 findings into practical assay logic while distinguishing pharmacological inhibition from GLI2-specific genetic evidence.
-
H 89 2HCl in Trigeminal Pain Signaling
2026-08-26
H 89 2HCl offers a pharmacological way to interrogate cAMP-dependent protein kinase inhibition in trigeminal pain models. This article connects PKA assay design with the CGRP/SP–Piezo2 neuroinflammatory axis while emphasizing selectivity, compartment-specific interpretation, and off-target controls.
-
Phosphatase Inhibitor Cocktail 3: Workflow Guide
2026-08-26
Phosphatase Inhibitor Cocktail 3 protects labile phosphorylation states during tissue and cell lysis, enabling cleaner Western blots, co-immunoprecipitation, and phosphoprotein analysis. This workflow explains how to use its 100X DMSO formulation, control assay variables, and translate findings from hepatic autophagy research into practical signaling experiments.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-08-25
Phosphatase Inhibitor Cocktail (2 Tubes, 100X) helps limit endogenous phosphatase activity during sample preparation so phosphorylation-dependent signals are less likely to change before analysis. It is suited to immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry workflows, but it should not be treated as a universal substitute for assay-specific validation or as a diagnostic or medical reagent.